17β-estradiol and/or estrogen receptor β attenuate the autophagic and apoptotic effects induced by prolonged hypoxia through HIF-1α-mediated BNIP3 and IGFBP-3 signaling blockage

Cellular Physiology and Biochemistry

Volumn 36, Issue 1, 2015, Pages 274-284

  Hsieh, Dennis Jine Yuan ^a,b   Kuo, Wei Wen ^c   Lai, Yi Ping ^c   Shibu, Marthandam Asokan ^c   Shen, Chia Yao ^d   Pai, Peiying ^e   Yeh, Yu Lan ^f   Lin, Jing Ying ^g   Viswanadha, Vijaya Padma ^h   Huang, Chih Yang ^c,i  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d MEIHO UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^g CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^h BHARATHIAR UNIVERSITY   (India)

ⁱ ASIA UNIVERSITY   (Taiwan)

Author keywords

17 estradiol; Autophagy; Cardiac apoptosis; Estrogen receptor ; Hypoxia

Indexed keywords

AUTOPHAGY PROTEIN 5; AUTOPHAGY PROTEIN 7; CASPASE 3; CASPASE 9; CYTOCHROME C; ESTRADIOL; ESTROGEN RECEPTOR ANTAGONIST; ESTROGEN RECEPTOR BETA; FULVESTRANT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN; PROTEIN BAD; PROTEIN BAK; PROTEIN BCL 2; PROTEIN BNIP3; PROTEIN KINASE B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; MEMBRANE PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DEATH; CONTROLLED STUDY; H9C2 CARDIOMYOBLAST CELL; HEART DISEASE; HEART PROTECTION; HYPOXIA; MUSCLE CELL; MYOBLAST; NEONATAL RAT VENTRICULAR MYOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TUNEL ASSAY; WILD TYPE; ANIMAL; CELL CULTURE; CELL HYPOXIA; CYTOLOGY; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE CELL; HUMAN; METABOLISM; NEWBORN; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; AUTOPHAGY; CELL HYPOXIA; CELLS, CULTURED; ESTRADIOL; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MEMBRANE PROTEINS; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84929883981     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000374070     Document Type: Article

References (34)

1. Lopez AD, Murray CC: The global burden of disease, 1990-2020. Nat Med 1998;4:1241-1243.
2. Mosca L, Barrett-Connor E, Wenger NK: Sex/gender differences in cardiovascular disease prevention: What a difference a decade makes. Circulation 2011;124:2145-2154.
3. Osborne CK, Zhao H, Fuqua SA: Selective estrogen receptor modulators: Structure, function, and clinical use. J Clin Oncol 2000;18:3172-3186.
4. Ylikorkala O: Hrt as secondary prevention of cardiovascular disease. Maturitas 2004;47:315-318.
5. Patten RD, Pourati I, Aronovitz MJ, Baur J, Celestin F, Chen X, Michael A, Haq S, Nuedling S, Grohe C, Force T, Mendelsohn ME, Karas RH: 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/akt signaling. Circ Res 2004;95:692-699.
6. Liou CM, Yang AL, Kuo CH, Tin H, Huang CY, Lee SD: Effects of 17beta-estradiol on cardiac apoptosis in ovariectomized rats. Cell Biochem Funct 2010;28:521-528.
7. Wu CH, Liu JY, Wu JP, Hsieh YH, Liu CJ, Hwang JM, Lee SD, Chen LM, Chang MH, Kuo WW, Shyu JC, Tsai JH, Huang CY: 17beta-estradiol reduces cardiac hypertrophy mediated through the up-regulation of pi3k/akt and the suppression of calcineurin/nf-at3 signaling pathways in rats. Life Sci 2005;78:347-356.
8. Osborne CK: Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat 1998;51:227-238.
9. Olefsky JM: Nuclear receptor minireview series. J Biol Chem 2001;276:36863-36864.
10. Tsai MJ, O'Malley BW: Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1994;63:451-486.
11. Tora L, White J, Brou C, Tasset D, Webster N, Scheer E, Chambon P: The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 1989;59:477-487.
12. Coleman KM, Dutertre M, El-Gharbawy A, Rowan BG, Weigel NL, Smith CL: Mechanistic differences in the activation of estrogen receptor-alpha (ER alpha)-and ER beta-dependent gene expression by camp signaling pathway(s). J Biol Chem 2003;278:12834-12845.
13. Delaunay F, Pettersson K, Tujague M, Gustafsson JA: Functional differences between the amino-terminal domains of estrogen receptors alpha and beta. Mol Pharmacol 2000;58:584-590.
14. Pearce ST, Jordan VC: The biological role of estrogen receptors alpha and beta in cancer. Crit Rev Oncol Hematol 2004;50:3-22.
15. Nilsson S, Gustafsson JA: Estrogen receptors: Therapies targeted to receptor subtypes. Clin Pharmacol Ther 2011;89:44-55.
16. Liu CJ, Lo JF, Kuo CH, Chu CH, Chen LM, Tsai FJ, Tsai CH, Tzang BS, Kuo WW, Huang CY: Akt mediates 17beta-estradiol and/or estrogen receptor-alpha inhibition of lps-induced tumor necresis factor-alpha expression and myocardial cell apoptosis by suppressing the jnk1/2-nfkappab pathway. J Cell Mol Med 2009;13:3655-3667.
17. Fliegner D, Schubert C, Penkalla A, Witt H, Kararigas G, Dworatzek E, Staub E, Martus P, Ruiz Noppinger P, Kintscher U, Gustafsson JA, Regitz-Zagrosek V: Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload. Am J Physiol Regul Integr Comp Physiol 2010;298:R1597-1606.
18. Pedram A, Razandi M, Lubahn D, Liu J, Vannan M, Levin ER: Estrogen inhibits cardiac hypertrophy: Role of estrogen receptor-beta to inhibit calcineurin. Endocrinology 2008;149:3361-3369.
19. Datta SR, Brunet A, Greenberg ME: Cellular survival: A play in three akts. Genes Dev 1999;13:2905-2927.
20. Chao W, Matsui T, Novikov MS, Tao J, Li L, Liu H, Ahn Y, Rosenzweig A: Strategic advantages of insulin-like growth factor-I expression for cardioprotection. J Gene Med 2003;5:277-286.
21. Camper-Kirby D, Welch S, Walker A, Shiraishi I, Setchell KD, Schaefer E, Kajstura J, Anversa P, Sussman MA: Myocardial akt activation and gender: Increased nuclear activity in females versus males. Circ Res 2001;88:1020-1027.
22. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, Bender JR: Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the pi3-kinase-akt pathway in human endothelial cells. Circ Res 2000;87:677-682.
23. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK: Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-oh kinase. Nature 2000;407:538-541.
24. Hisamoto K, Ohmichi M, Kurachi H, Hayakawa J, Kanda Y, Nishio Y, Adachi K, Tasaka K, Miyoshi E, Fujiwara N, Taniguchi N, Murata Y: Estrogen induces the akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem 2001;276:3459-3467.
25. Kang PM, Izumo S: Apoptosis and heart failure: A critical review of the literature. Circ Res 2000;86:1107-1113.
26. van Eickels M, Patten RD, Aronovitz MJ, Alsheikh-Ali A, Gostyla K, Celestin F, Grohe C, Mendelsohn ME, Karas RH: 17-beta-estradiol increases cardiac remodeling and mortality in mice with myocardial infarction. J Am Coll Cardiol 2003;41:2084-2092.
27. Zhao ZQ, Nakamura M, Wang NP, Wilcox JN, Shearer S, Ronson RS, Guyton RA, Vinten-Johansen J: Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res 2000;45:651-660.
28. Palojoki E, Saraste A, Eriksson A, Pulkki K, Kallajoki M, Voipio-Pulkki LM, Tikkanen I: Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 2001;280:H2726-2731.
29. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM: Apoptosis in human acute myocardial infarction. Circulation 1997;95:320-323.
30. Olivetti G, Quaini F, Sala R, Lagrasta C, Corradi D, Bonacina E, Gambert SR, Cigola E, Anversa P: Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 1996;28:2005-2016.
31. Abbate A, Biondi-Zoccai GG, Bussani R, Dobrina A, Camilot D, Feroce F, Rossiello R, Baldi F, Silvestri F, Biasucci LM, Baldi A: Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. J Am Coll Cardiol 2003;41:753-760.
32. Hale SL, Birnbaum Y, Kloner RA: Estradiol, administered acutely, protects ischemic myocardium in both female and male rabbits. J Cardiovasc Pharmacol Ther 1997;2:47-52.
33. Node K, Kitakaze M, Kosaka H, Minamino T, Funaya H, Hori M: Amelioration of ischemia-and reperfusion-induced myocardial injury by 17beta-estradiol: Role of nitric oxide and calcium-activated potassium channels. Circulation 1997;96:1953-1963.
34. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial. JAMA 2002;288:321-333.